About Biotage
Biotage is a publicly listed company based in Uppsala (Sweden) founded in 2009, and was acquired by KKR in April 2025. Organic synthesis, analytical, and peptide chemistry services for drug discovery and development. The company has 11 employees. Biotage has completed 6 acquisitions, including ATDBio, Astrea Bioseparations and Horizon Technology. Its website biotage.com draws about 40 thousand monthly visits. Its Indian entity Biotage India Private Limited reported revenue of ₹10.72 Cr. Biotage offers products and services including Biotage® Initiator+, Biotage® Selekt, Biotage® V-10 Touch, and ISOLUTE® SCX-2. Its focus areas include Biopharma Outsourcing, Diversified and Biologics.
Company details
Biotage was founded in 2009 in Uppsala, Sweden, and operates within the biotechnology sector focused on chemistry solutions. Products and services are offered in organic synthesis, analytical chemistry, and industrial resins, including separation technologies scaled from analysis to industrial levels. High-quality medical, analytical, and peptide chemistry solutions are provided for research and commercial applications. These are utilized by government authorities, academic institutions, pharmaceutical firms, and food companies.
- Headquarters Uppsala, Sweden
- Employees 11
- Stage Public
- SectorsHealthcare
- Website biotage.com
- Social LinkedIn X Facebook
- Acquired by KKR (Apr 2025)
- Legal Name Biotage India Private Limited
- Date of Incorporation 11 Oct, 2017
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹10.72 Cr
FY 2024 · +17% YoY
- Indian entity net profit₹1.04 Cr
FY 2024 · 10% margin
- Indian entity EBITDA₹1.74 Cr
FY 2024 · 16% margin
- Latest Funding Round$2.35K (USD), Grant
Jan 2017
- InvestorsKKR
& 1 more
- Employee Count11
- Investments & AcquisitionsATDBio
& 5 more
- Acquired byKKR
(Apr 2025)
Associated legal entities of Biotage
Biotage operates through Biotage India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biotage India Private Limited CIN U74999DL2017FTC364509 | Active | 11 Oct 2017 | New Delhi, Delhi | ₹10.7 Cr | 11 | 3 | View details |
Products & Services of Biotage
Biotage offers a comprehensive portfolio of products and services, including Biotage® Initiator+, Biotage® Selekt, Biotage® V-10 Touch, and ISOLUTE® SCX-2.
Microwave synthesizer for efficient organic chemistry workflows
System for purification in drug discovery applications
Tool for sample evaporation and concentration processes
Product for solid phase extraction in analytical testing
Funding Insights of Biotage
- Total Rounds 2
- Last Round Grant — $2,353
- Investors Count 1
All 2 funding rounds of Biotage with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $2,353 | Grant | – | – | |
| Jun 2015 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Biotage
Biotage has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include KKR and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Biotage
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biotage India Private Limited (Biotage)
Biotage India Private Limited is the primary company behind Biotage. The board of Biotage India Private Limited currently have 3 directors; the longest-serving is Nimisha Pandey, appointed in 2018. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nimisha Pandey DIN 08254625 | Director | 11 Oct 2018 | 8 yrs 1 mo | Biotage India Private Limited |
| Scott Everett Carr DIN 10783569 | Additional Director | 27 Sep 2024 | 2 yrs 1 mo | Biotage India Private Limited |
| Gokulakrishnan Srinivasan DIN 10937456 | Additional Director | 06 Feb 2025 | 1 yr 9 mo | Biotage India Private Limited |
People of Biotage
89 people are tracked at Biotage (28 in leadership, 8 in board & advisors, 53 in team); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Ulrika Bergström | Head Of Group Accounting | Leadership |
Andreas Juhlin | President International | Leadership |
Lee Williams | Director Analytical Product And Consumable Development | Leadership |
Carina Wimmerstedt | HR Director International | Leadership |
Adam Gould | Director Strategic Accounts, & Oligonucleotides - North America | Leadership |
Patrick Kohlhaas | Associate Director Strategic Accounts Organic & Peptide Chemistry, Biomolecules, Clinical Testing | Leadership |
Lee Hoang | Director Of Research Development | Leadership |
Jan Rensberg | Commercial Director EMEA Interim | Leadership |
Toshi Yachi | General Manager APAC | Leadership |
Frida Peacock | HR Business Partner | Leadership |
Mario Merida | Associate Director, Strategic Accounts-life Sciences | Leadership |
Farah Mavandadi | Director Of Marketing And Applications Support | Leadership |
Gabriel Gomez | Director Of Service, Americas | Leadership |
Morgan Stamp | Human Resources Business Partner | Leadership |
Tim Jones | EMEA Sales Director, Small Molecules & Biomolecules | Leadership |
Tobias Nordin | Director Of Technical Development | Leadership |
| Marketing Director International | Leadership | |
Petra Duprez | Chief Human Resources & Sustainability Officer | Leadership |
Anna Cederlöf | Director Project & Program Management R&d | Leadership |
Marita Källberg | Accounting Director | Leadership |
69 more people are available in the full profile.
Complete people profiles for Biotage
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Biotage
Figures of Biotage India Private Limited, the primary company behind Biotage, for FY 2024. Revenue was ₹10.72 Cr (+17% year on year). Net profit was ₹1.04 Cr (10% margin). EBITDA was ₹1.74 Cr (16% margin). Revenue has grown at a compounded annual rate of +18% over three years and +58% over five years.
- ₹10.72 CrRevenue · FY 2024 · +17% YoY
- ₹1.04 CrNet profit · 10% margin
- ₹1.74 CrEBITDA · 16% margin
- ₹2.04 CrPaid-up capital
- 11Employees (provident fund records)
- +18%Revenue CAGR, 3 years
- +58%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biotage India Private Limited are on its company page.
Detailed financial statements for Biotage
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biotage
Biotage has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include ATDBio, Astrea Bioseparations and Horizon Technology.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Purification and separation tools are supplied for therapeutic development. | astreabioseparations.com | Cambridge, United Kingdom | 1987 | Feb 2023 | $215M | |
Developer of oligonucleotides | atdbio.com | Southampton, United Kingdom | 2005 | Oct 2021 | •••• | |
Molecular biology research products and automated extractors are developed. | phynexus.com | San Jose, United States | 2002 | Dec 2018 | $21.5M | |
R&D company focused on manufacturing drugs for multiple therapeutic areas | horizontechinc.com | Salem, United States | 1992 | Dec 2017 | $18.4M | |
Manufacturer of polymeric separation resins | miptechnologies.com | Lund, Sweden | 1999 | Apr 2010 | •••• | |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. | personalchemistry.com | Uppsala, Sweden | 1998 | Aug 2003 | •••• |
Complete acquisition details for Biotage
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Biotage
11 dated milestones of Biotage across 22 years, from founding to its latest funding, stage changes and deals.
- Acquisition Acquires Personal Chemistry.
- IPO Lists on the stock exchange (IPO).
- Founded Biotage is founded.
- Acquisition Acquires MIP Technologies.
- Funding First funding round.
- Funding Latest funding round, Grant, of $2K.
- Acquisition Acquires Horizon Technology.
- Acquisition Acquires PhyNexus.
- Acquisition Acquires ATDBio.
- Acquisition Acquires Astrea Bioseparations.
- Exit Acquired by KKR.
Web traffic of Biotage
The website of Biotage (biotage.com) receives about 39.5K visits a month.
- Monthly visits39.5K
▲ 0.8% vs previous month
Websites whose visitors overlap most with Biotage. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| waters.com | 100% | 416.8K | #124,184 | View details | |
| perkinelmer.com | 99% | 164.5K | #258,286 | View details | |
cem.com | cem.com | 84% | #684,006 | – | |
| sorbtech.com | 84% | #2,696,977 | View details | ||
| activotec.com | 82% | 2K | #9,879,261 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Biotage
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biotage
Complete news archive for Biotage
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biotage
Biotage was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Biotage is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.
Biotage has 11 employees.
The primary company behind Biotage, Biotage India Private Limited, reported revenue of ₹10.72 Cr for FY 2024, up 17% year on year.
Biotage was founded in 2009 in Uppsala, Sweden, and operates within the biotechnology sector focused on chemistry solutions. Products and services are offered in organic synthesis, analytical chemistry, and industrial resins, including separation technologies scaled from analysis to industrial levels. High-quality medical, analytical, and peptide chemistry solutions are provided for research and commercial applications. These are utilized by government authorities, academic institutions, pharmaceutical firms, and food companies.
Biotage offers Biotage® Initiator+, Biotage® Selekt, Biotage® V-10 Touch, and ISOLUTE® SCX-2.
Biotage has made 6 acquisitions, including ATDBio, Astrea Bioseparations, and Horizon Technology.
Biotage has 2 investors. Key investors include KKR, and European Union.
Biotage operates through Biotage India Private Limited.
Yes. Biotage was acquired by KKR in April 2025.
The legal entities of Biotage currently have 3 directors, including Scott Everett Carr, Nimisha Pandey, Gokulakrishnan Srinivasan.